 | Up a level |
Block, Martin; Gründker, Carsten; Fister, Stefanie; Kubin, Julia; Wilkens, Ludwig; Mueller, Michael D; Hemmerlein, Bernhard; Emons, Günter; Günthert, Andreas R (2012). Inhibition of the AKT/mTOR and erbB pathways by gefitinib, perifosine and analogs of gonadotropin-releasing hormone I and II to overcome tamoxifen resistance in breast cancer cells. International journal of oncology, 41(5), pp. 1845-54. Athens: Spandidos Publications 10.3892/ijo.2012.1591
Emons, Günter; Kaufmann, Manfred; Gorchev, Grigor; Tsekova, Valentina; Gründker, Carsten; Günthert, Andreas R; Hanker, Lars C; Velikova, Maya; Sindermann, Herbert; Engel, Jürgen; Schally, Andrew V (2010). Dose escalation and pharmacokinetic study of AEZS-108 (AN-152), an LHRH agonist linked to doxorubicin, in women with LHRH receptor-positive tumors. Gynecologic oncology, 119(3), pp. 457-61. Orlando, Fla.: Elsevier 10.1016/j.ygyno.2010.08.003
Gründker, Carsten; Föst, Crispin; Fister, Stefanie; Nolte, Nadine; Günthert, Andreas R; Emons, Günter (2010). Gonadotropin-releasing hormone type II antagonist induces apoptosis in MCF-7 and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo. Breast cancer research, 12(4), R49. London: BioMed Central Ltd. 10.1186/bcr2606
Block, Martin; Fister, Stefanie; Emons, Günter; Seeber, Sandrine; Gründker, Carsten; Günthert, Andreas R (2010). Antiproliferative effects of antiestrogens and inhibitors of growth factor receptor signaling on endometrial cancer cells. Anticancer research, 30(6), pp. 2025-31. Kapandriti: International Inst. of Anticancer Research
